Author:
Levitt N C,Propper D J,Madhusudan S,Braybrooke J P,Echeta C,te Poele R,Davies S L,Flanagan E,Hickson I D,Joel S,Ganesan T S
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K (1994) Current Protocols In Molecular Biology. New York: John Wiley & Sons
2. Bertrand R, O'Connor PM, Kerrigan D, Pommier Y (1992) Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells. Eur J Cancer 28: 743–748
3. Bonner JA, Kozelsky TF (1996) The significance of the sequence of administration of topotecan and etoposide. Cancer Chemother Pharmacol 39: 109–112
4. Bookman MA, Malmstrom H, Bolis G, Gordon A, Lissoni A, Krebs JB, Fields SZ (1998) Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel. J Clin Oncol 16: 3345–3352
5. Braybrooke JP, Levitt NC, Joel S, Davis T, Madhusudan S, Turley H, Wilner S, Harris AL, Talbot DC (2003) Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression. Clin Cancer Res 9: 4682–4688
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献